Irritable Mood clinical trials at UC Davis
1 research study open to eligible people
Tolerability, safety, and activity of experimental medicine, SRX246 in irritable patients with Huntington's Disease
“Does experimental medicine, SRX246 help treat irritability in Huntington's Disease patients?”
open to eligible people ages 18 years and up
This study evaluates the tolerability, safety and activity of SRX246 in the treatment of irritability in patients with Huntington's disease. Two-thirds of all participants will receive SRX246, while the other third will receive a placebo.
Sacramento, California and other locations